Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer

IntroductionProstate cancer (PCa) is the second most frequent cancer diagnosis in men and the fifth leading cause of death worldwide. Prostate Specific Membrane Antigen (PSMA) and Gastrin Releasing Peptide (GRP) receptors are overexpressed in PCa. In this study, we have developed iron oxide nanopart...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Danae Efremia Bajwa, Evangelia-Alexandra Salvanou, Maria Theodosiou, Theodora S. Koutsikou, Eleni K. Efthimiadou, Penelope Bouziotis, Christos Liolios
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2023-09-01
Serija:	Frontiers in Nuclear Medicine
Teme:	prostate cancer PSMA bombesin bispecific heterodimers iron oxide nanoparticles 99mTc
Online dostop:	https://www.frontiersin.org/articles/10.3389/fnume.2023.1184309/full
Oznake:	Označite Brez oznak, prvi označite!